Edition:
India

Shilpa Medicare Ltd (SHME.NS)

SHME.NS on National Stock Exchange of India

594.05INR
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
Rs594.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
33,575
52-wk High
Rs749.90
52-wk Low
Rs535.10

Chart for

About

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The Company's segments include Bulk Drug/Intermediates and Energy. It offers 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug... (more)

Overall

Beta: 0.42
Market Cap(Mil.): Rs50,159.44
Shares Outstanding(Mil.): 80.13
Dividend: 0.60
Yield (%): 0.10

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Shilpa Medicare Gets 483 Observations From U.S. FDA For SEZ Formulation Facilities In Telangana

* SAYS GOT 483 OBSERVATIONS FROM U.S. FDA IN RELATION TO SEZ FORMULATION FACILITIES SITUATED AT JADCHERLA, TELANGANA

05 Dec 2017

BRIEF-India's Shilpa Medicare Sept-qtr profit rises

* Sept quarter profit 481.9 million rupees versus 331.9 million rupees year ago

13 Nov 2017

BRIEF-India's Shilpa Medicare says Rajendra Dugar resigns as CFO

* Says Rajendra Dugar resigns as CFO Source text - http://bit.ly/2z4zHTh Further company coverage:

24 Oct 2017

BRIEF-India's Shilpa Medicare June-qtr profit rises

* June quarter profit 278.8 million rupees versus profit of 240.9 million rupees year ago

10 Aug 2017

BRIEF-India cenbank says FIIs/FPIs can now invest 30-40 pct in Shilpa Medicare

* FIIs/FPIs can now invest 30 to 40 per cent under PIS in Shilpa Medicare Limited Source text - (http://bit.ly/2uyzCV4) Further company coverage:

18 Jul 2017

Earnings vs. Estimates